Chemed Corp
Research Chemed Corp (CHE) on Bullrun: valuation model: 3.1% overvalued, market cap USD 7.08B, P/E 27.3, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCHE
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyUSD
- Valuation signal3.1% overvalued
- Market capUSD 7.08B
- P/E27.3
- Dividend yield0.5%
- Financial periodQ1 2026
- RevenueUSD 657.51M
- Net incomeUSD 66.30M
- Free cash flowUSD 71.10M
- Gross margin32.8%
Valuation Snapshot
Bullrun's latest valuation model marks Chemed Corp as 3.1% overvalued; latest market cap is USD 7.08B; P/E is 27.3; dividend yield is 0.5%.
Peer valuation comparison
Latest P/E is 27.32x versus a Healthcare sector median of 24.46x (11.7% above).
Latest dividend yield is 0.48% versus a Healthcare sector median of 2.11% (77.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.53B | USD 265.24K | USD 325.48M | 32.5% | 18.34 | USD 74.52M | USD 143.76M | USD 979.41M |
| FY2024 | USD 1.53B | USD 302.00K | USD 367.97M | -3.0% | 19.89 | USD 178.35M | USD 140.84M | USD 1.12B |
| FY2023 | USD 1.32B | USD 272.51K | USD 273.45M | -11.4% | 17.93 | USD 263.96M | USD 139.41M | USD 1.11B |
| FY2022 | USD 1.20B | USD 249.62K | USD 252.56M | -14.0% | 16.53 | USD 74.13M | USD 97.50M | USD 798.72M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 7.08B | 27.3 | 0.5% | 2.5 |
| 2025 | 2025-12-31 | USD 5.87B | 23.3 | 0.5% | 2.2 |
| 2024 | 2024-12-31 | USD 7.71B | 26.6 | 0.3% | 1.8 |
| 2023 | 2023-12-29 | USD 8.78B | 36.2 | 0.3% | 1.56 |
| 2022 | 2022-12-30 | USD 7.59B | 29.7 | 0.3% | 1.48 |
| 2021 | 2021-12-31 | USD 7.89B | 31.3 | 0.3% | 1.4 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.5 USD, yield 0.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.2 USD |
| FY2024 | 1.8 USD |
| FY2023 | 1.56 USD |
| FY2022 | 1.48 USD |
About Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Chemed Corp overvalued or undervalued?
Bullrun's valuation model currently marks Chemed Corp as 3.1% overvalued.
What is Chemed Corp's market cap?
Chemed Corp's market capitalization is USD 7.08B.
What is Chemed Corp's P/E ratio?
Chemed Corp's price-to-earnings (P/E) ratio is 27.3.
Does Chemed Corp pay a dividend?
Chemed Corp has a dividend yield of 0.5%.
What does Chemed Corp do?
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.